LifeVest Insight Case Studies
LifeVest Insight Homepage »Learn how the LifeVest® wearable cardioverter defibrillator (WCD) captured arrhythmic events that enabled physicians to modify the treatment path for their patients.
Atrial Fibrillation
Newly diagnosed heart failure patient with an EF of 20%. Atrial fibrillation events recorded by LifeVest altered the course of treatment for the patient.
Bradycardia
NSTEMI patient with an EF of 30%. Bradycardia events recorded by LifeVest revealed significant underlying cardiovascular disease.
Sinus Tachycardia
STEMI patient post-PCI with an EF of 29%. Sinus tachycardia events recorded by LifeVest altered the course of treatment for the patient.
Sustained VT
Dilated cardiomyopathy patient with an EF of ≤ 35%. A ventricular tachycardia event recorded by LifeVest altered the course of treatment for the patient.
Syncope
STEMI patient with an EF of 30%. Data recorded by LifeVest revealed recurring bradycardia events that required pacemaker implantation.
Trends
Non-ischemic cardiomyopathy patient with an EF of 20%. Data collected from LifeVest altered the course of treatment for the patient.
LifeVest can capture arrhythmic events including: Sustained VT, Non-Sustained VT, Atrial Arrhythmias/SVT,* Severe Bradycardia/Asystole.
*When the rhythm meets heart rate and morphology criteria, or through a patient initiated recording.